About Us
It is primarily set up to develop and commercialize non-invasive, protein-based diagnostic applications.
First diagnostic applications in development are based on the proprietary bladder cancer biomarkers and detection antibodies discovered and developed in A*STAR’s Institute of Molecular and Cell Biology (IMCB) by BioCheetah’s Scientific Founder (Prof. Jean Paul Thiery) and the co-Founder/Chief Executive Officer (Dr. Kian-Chung Lee).
Read More
Products
An algorithm has been created to enable a more accurate and conclusive testing result
